Response to: 'Comment on: 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Gossec et al' by Wei et al

Author(s):: Gossec, L.; Baraliakos, X.; McInnes, I.; Kerschbaumer, A.; Wit, M. de; Dougados, M.; Primdahl, J.; Heijde, D. van der; Smolen, J.S.

Published: 2022
Publication type: Article / Letter to editor

arthritispsoriaticbiological therapyepidemiology

Date issued: 2022-08-01
Language: English
Publisher: BMJ PUBLISHING GROUP
Is part of
hdl: 1887/3458782
doi: 10.1136/annrheumdis-2020-218456
URL: https://ard.bmj.com/content/81/8/e139